POM-V
Prescription Required
Companion Animal
Valemas 50 mg/ml Solution for Injection for Cattle, Sheep, Goats, Pigs, Dogs and Cats
Active ingredient: Enrofloxacin
Form
Injection
Species
Cats
Cattle
Dogs
Goats
Pigs
Sheep
Manufacturer
Fatro S.p.A.
VMD MA No.
11557/4003
What it's used for
Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of Escherichia coli. Treatment of septicaemia caused by enroflox...
Full indications, dosage and side effects ↓The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.
Paying less for Enrofloxacin
-
1
Ask your vet for a written prescription
They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
-
2
Fill it at a registered online retailer
The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.
Done — we'll email you when prices land.
Prescription required
Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.
Clinical information
Valemas 50 mg/ml Solution for Injection for Cattle, Sheep, Goats, Pigs, Dogs and Cats — SPC Details
Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.
Treatment of infections of the alimentary tract caused by enrofloxacin susceptible
strains of Escherichia coli.
Treatment of septicaemia caused by enrofloxacin susceptible strains of
coli.
Treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible
strains of Mycoplasma bovis.
Sheep
Treatment of infections of the alimentary tract caused by enrofloxacin susceptible
strains of Escherichia coli.
Treatment of septicaemia caused by enrofloxacin susceptible strains of
coli.
Unlimited Renewal: September 2023
Treatment of mastitis caused by enrofloxacin susceptible strains of
aureus Escherichia coli.
Goats
Treatment of infections of the respiratory tract caused by enrofloxacin susceptible
strains of Pasteurella multocida Mannheimia haemolytica
Treatment of infections of the alimentary tract caused by enrofloxacin susceptible
strains of Escherichia coli.
Treatment of septicaemia caused by enrofloxacin susceptible strains of
coli
Treatment of mastitis caused by enrofloxacin susceptible strains of
aureus Escherichia coli.
Pigs
Treatment of infections of the respiratory tract caused by enrofloxacin susceptible
strains of ,
pleuropneumoniae.
Treatment of infections of the alimentary tract caused by enrofloxacin susceptible
strains of Escherichia coli.
Treatment of septicaemia caused by enrofloxacin susceptible strains of
coli.
Dogs
Treatment of infections of the alimentary, respiratory and urogenital tracts (including
prostatitis, adjunctive antibiotic therapy for pyometra), skin and wound infections, otitis
(externa/media) caused by enrofloxacin susceptible strains of
Escherichia coli, pp., pp.,
and Proteus spp.
Cats
Treatment of infections of the alimentary, respiratory and urogenital tracts (as
adjunctive antibiotic therapy for pyometra), skin and wound infections, caused by
enrofloxacin susceptible strains of, e.g.: ,
Pasteurella
strains of Escherichia coli.
Treatment of septicaemia caused by enrofloxacin susceptible strains of
coli.
Treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible
strains of Mycoplasma bovis.
Sheep
Treatment of infections of the alimentary tract caused by enrofloxacin susceptible
strains of Escherichia coli.
Treatment of septicaemia caused by enrofloxacin susceptible strains of
coli.
Unlimited Renewal: September 2023
Treatment of mastitis caused by enrofloxacin susceptible strains of
aureus Escherichia coli.
Goats
Treatment of infections of the respiratory tract caused by enrofloxacin susceptible
strains of Pasteurella multocida Mannheimia haemolytica
Treatment of infections of the alimentary tract caused by enrofloxacin susceptible
strains of Escherichia coli.
Treatment of septicaemia caused by enrofloxacin susceptible strains of
coli
Treatment of mastitis caused by enrofloxacin susceptible strains of
aureus Escherichia coli.
Pigs
Treatment of infections of the respiratory tract caused by enrofloxacin susceptible
strains of ,
pleuropneumoniae.
Treatment of infections of the alimentary tract caused by enrofloxacin susceptible
strains of Escherichia coli.
Treatment of septicaemia caused by enrofloxacin susceptible strains of
coli.
Dogs
Treatment of infections of the alimentary, respiratory and urogenital tracts (including
prostatitis, adjunctive antibiotic therapy for pyometra), skin and wound infections, otitis
(externa/media) caused by enrofloxacin susceptible strains of
Escherichia coli, pp., pp.,
and Proteus spp.
Cats
Treatment of infections of the alimentary, respiratory and urogenital tracts (as
adjunctive antibiotic therapy for pyometra), skin and wound infections, caused by
enrofloxacin susceptible strains of, e.g.: ,
Pasteurella
Do not use in animals with known hypersensitivity to enrofloxacin or other
fluoroquinolones or to any of the excipients.
Do not use in animals that are epileptic or suffer from seizures since enrofloxacin may
cause CNS stimulation.
Do not use in young dogs during their growth, i.e. in small breeds of dogs less than 8
months of age, in big breeds of dogs less than 12 months of age, in giant breeds of
dogs less than 18 months of age.
Do not use in cats less than 8 weeks of age.
Do not use in growing horses because of possible deleterious damage on articular
cartilage.
fluoroquinolones or to any of the excipients.
Do not use in animals that are epileptic or suffer from seizures since enrofloxacin may
cause CNS stimulation.
Do not use in young dogs during their growth, i.e. in small breeds of dogs less than 8
months of age, in big breeds of dogs less than 12 months of age, in giant breeds of
dogs less than 18 months of age.
Do not use in cats less than 8 weeks of age.
Do not use in growing horses because of possible deleterious damage on articular
cartilage.
Digestive tract disorders (e.g. diarrhoea) may occur in very rare cases. These signs
are generally mild and transient.
Local reactions at injection site
In calves, transient local tissue reactions may occur in very rare cases and may be
observed up to 14 days.
Unlimited Renewal: September 2023
In pigs, after intramuscular administration of the product, inflammatory reactions may
occur. They may persist up to 28 days after the injection.
In dogs, a moderate and transient local reaction (such as oedema) may occur.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s));
- common (more than 1 but less than 10 animals in 100 animals treated);
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated);
- rare (more than 1 but less than 10 animals in 10,000 animals treated);
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
are generally mild and transient.
Local reactions at injection site
In calves, transient local tissue reactions may occur in very rare cases and may be
observed up to 14 days.
Unlimited Renewal: September 2023
In pigs, after intramuscular administration of the product, inflammatory reactions may
occur. They may persist up to 28 days after the injection.
In dogs, a moderate and transient local reaction (such as oedema) may occur.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s));
- common (more than 1 but less than 10 animals in 100 animals treated);
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated);
- rare (more than 1 but less than 10 animals in 10,000 animals treated);
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
None.
Unlimited Renewal: September 2023
Special precautions for use in animals
Official and local antimicrobial policies should be taken into account when the product
is used.
Fluoroquinolones should be reserved for the treatment of clinical conditions which have
responded poorly, or are expected to respond poorly, to other classes of antimicrobials.
Whenever possible fluoroquinolones should only be used based on susceptibility
testing.
Use of the product including use deviating from the instructions given in the SPC may
increase the prevalence of bacteria resistant to enrofloxacin and may decrease the
effectiveness of treatment with all fluoroquinolones due to the potential for cross-
resistance.
Special caution should be taken when using enrofloxacin in animals with impaired renal
function.
Special caution should be taken when using enrofloxacin in cats because higher doses
than recommended can cause retinal damage and blindness (see section 4.10).
Degenerative changes of articular cartilage were observed in calves treated orally with
30 mg enrofloxacin/kg body weight during 14 days.
The use of enrofloxacin in growing lambs at the recommended dose for 15 days
caused histological changes in the articular cartilage, not associated to clinical signs.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
People with known hypersensitivity to (fluoro) quinolones should avoid any contact with
the product.
Valemas may cause skin and eye irritation. Avoid skin and eye contact. Wash any
splashes from skin or eyes immediately with water.
Do not eat, drink or smoke whilst handling the product.
Care should be taken to avoid accidental self-injection. In case of accidental self-
injection seek medical advice immediately and show the package leaflet or label to the
physician
Wash hands after use.
Other precautions
In countries where feeding of fallen stock to scavenger bird populations is permitted as
a conservation measure (see Commission Decision 2003/322/EC), the possible risk to
hatching success should be considered before feeding carcasses of livestock recently
treated with this product.
Unlimited Renewal: September 2023
Special precautions for use in animals
Official and local antimicrobial policies should be taken into account when the product
is used.
Fluoroquinolones should be reserved for the treatment of clinical conditions which have
responded poorly, or are expected to respond poorly, to other classes of antimicrobials.
Whenever possible fluoroquinolones should only be used based on susceptibility
testing.
Use of the product including use deviating from the instructions given in the SPC may
increase the prevalence of bacteria resistant to enrofloxacin and may decrease the
effectiveness of treatment with all fluoroquinolones due to the potential for cross-
resistance.
Special caution should be taken when using enrofloxacin in animals with impaired renal
function.
Special caution should be taken when using enrofloxacin in cats because higher doses
than recommended can cause retinal damage and blindness (see section 4.10).
Degenerative changes of articular cartilage were observed in calves treated orally with
30 mg enrofloxacin/kg body weight during 14 days.
The use of enrofloxacin in growing lambs at the recommended dose for 15 days
caused histological changes in the articular cartilage, not associated to clinical signs.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
People with known hypersensitivity to (fluoro) quinolones should avoid any contact with
the product.
Valemas may cause skin and eye irritation. Avoid skin and eye contact. Wash any
splashes from skin or eyes immediately with water.
Do not eat, drink or smoke whilst handling the product.
Care should be taken to avoid accidental self-injection. In case of accidental self-
injection seek medical advice immediately and show the package leaflet or label to the
physician
Wash hands after use.
Other precautions
In countries where feeding of fallen stock to scavenger bird populations is permitted as
a conservation measure (see Commission Decision 2003/322/EC), the possible risk to
hatching success should be considered before feeding carcasses of livestock recently
treated with this product.
Do not use enrofloxacin concomitantly with antimicrobial substances acting
antagonistically to quinolones (e.g. macrolides, tetracyclines or phenicols).
Do not use concurrently with theophylline as the elimination of theophylline may be
delayed.
Care should be taken during the concomitant use of flunixin and enrofloxacin in dogs
to avoid adverse drug reactions. The decrease in drug clearances as a result of co-
administration of flunixin and enrofloxacin indicates that these substances interact
during the elimination phase. Thus, in dogs, the co-administration of enrofloxacin and
flunixin increased the AUC and the elimination half-life of flunixin and increased the
elimination half-life and reduced the Cmax of enrofloxacin.
antagonistically to quinolones (e.g. macrolides, tetracyclines or phenicols).
Do not use concurrently with theophylline as the elimination of theophylline may be
delayed.
Care should be taken during the concomitant use of flunixin and enrofloxacin in dogs
to avoid adverse drug reactions. The decrease in drug clearances as a result of co-
administration of flunixin and enrofloxacin indicates that these substances interact
during the elimination phase. Thus, in dogs, the co-administration of enrofloxacin and
flunixin increased the AUC and the elimination half-life of flunixin and increased the
elimination half-life and reduced the Cmax of enrofloxacin.
This veterinary medicinal product does not require any special storage conditions.
Special precautions for use in animals
Official and local antimicrobial policies should be taken into account when the product
is used.
Fluoroquinolones should be reserved for the treatment of clinical conditions which have
responded poorly, or are expected to respond poorly, to other classes of antimicrobials.
Whenever possible fluoroquinolones should only be used based on susceptibility
testing.
Use of the product including use deviating from the instructions given in the SPC may
increase the prevalence of bacteria resistant to enrofloxacin and may decrease the
effectiveness of treatment with all fluoroquinolones due to the potential for cross-
resistance.
Special caution should be taken when using enrofloxacin in animals with impaired renal
function.
Special caution should be taken when using enrofloxacin in cats because higher doses
than recommended can cause retinal damage and blindness (see section 4.10).
Degenerative changes of articular cartilage were observed in calves treated orally with
30 mg enrofloxacin/kg body weight during 14 days.
The use of enrofloxacin in growing lambs at the recommended dose for 15 days
caused histological changes in the articular cartilage, not associated to clinical signs.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
People with known hypersensitivity to (fluoro) quinolones should avoid any contact with
the product.
Valemas may cause skin and eye irritation. Avoid skin and eye contact. Wash any
splashes from skin or eyes immediately with water.
Do not eat, drink or smoke whilst handling the product.
Care should be taken to avoid accidental self-injection. In case of accidental self-
injection seek medical advice immediately and show the package leaflet or label to the
physician
Wash hands after use.
Other precautions
In countries where feeding of fallen stock to scavenger bird populations is permitted as
a conservation measure (see Commission Decision 2003/322/EC), the possible risk to
hatching success should be considered before feeding carcasses of livestock recently
treated with this product.
4.
Official and local antimicrobial policies should be taken into account when the product
is used.
Fluoroquinolones should be reserved for the treatment of clinical conditions which have
responded poorly, or are expected to respond poorly, to other classes of antimicrobials.
Whenever possible fluoroquinolones should only be used based on susceptibility
testing.
Use of the product including use deviating from the instructions given in the SPC may
increase the prevalence of bacteria resistant to enrofloxacin and may decrease the
effectiveness of treatment with all fluoroquinolones due to the potential for cross-
resistance.
Special caution should be taken when using enrofloxacin in animals with impaired renal
function.
Special caution should be taken when using enrofloxacin in cats because higher doses
than recommended can cause retinal damage and blindness (see section 4.10).
Degenerative changes of articular cartilage were observed in calves treated orally with
30 mg enrofloxacin/kg body weight during 14 days.
The use of enrofloxacin in growing lambs at the recommended dose for 15 days
caused histological changes in the articular cartilage, not associated to clinical signs.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
People with known hypersensitivity to (fluoro) quinolones should avoid any contact with
the product.
Valemas may cause skin and eye irritation. Avoid skin and eye contact. Wash any
splashes from skin or eyes immediately with water.
Do not eat, drink or smoke whilst handling the product.
Care should be taken to avoid accidental self-injection. In case of accidental self-
injection seek medical advice immediately and show the package leaflet or label to the
physician
Wash hands after use.
Other precautions
In countries where feeding of fallen stock to scavenger bird populations is permitted as
a conservation measure (see Commission Decision 2003/322/EC), the possible risk to
hatching success should be considered before feeding carcasses of livestock recently
treated with this product.
4.
This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.
Medication costs adding up?
Pet insurance can cover prescription medications. Find the right policy for your pet.
Related Conditions
Same active ingredient
Other Products Containing Enrofloxacin
These products share the same active ingredient and may be suitable alternatives. Always consult your vet.
Baytril 100 mg/ml Solution for Injection
POM-VElanco GmbH
injection
Cattle
Goats
Pigs
Baytril 100 mg/ml Solution for Injection
POM-VElanco GmbH
injection
Cattle
Goats
Pigs
Baytril 100 mg/ml Solution for use in Drinking Water for Chickens, Turkeys and Rabbits
POM-VElanco GmbH
solution
Chickens
Rabbits
Turkeys
Baytril 100 mg/ml Solution for use in Drinking Water for Chickens, Turkeys and Rabbits
POM-VElanco GmbH
solution
Chickens
Rabbits
Turkeys
Baytril 25 mg/ml Oral Solution
POM-VElanco GmbH
liquid
Cattle
Exotic Animal
Reptiles
Baytril 25 mg/ml Oral Solution
POM-VElanco GmbH
liquid
Cattle
Exotic Animal
Reptiles
Alternative options to consider
Retailers we earn a commission from. It costs you nothing and never changes what we show.
The Pharm Pet Co.
The Pharm Pet Co. — Pet Pharmacy
UK online pet pharmacy. Flea, worm, prescription medications, supplements and pet food. Save vs vet prices.
Save up to 50%
Shop now
Pharmacy2U
Pet Care at Pharmacy2U
The UK's largest online pharmacy. Pet wormers, flea treatments, dental and joint care. Free delivery on orders over £30.
Free delivery £30+
Shop now
Petlibro
Petlibro Automatic Feeder
Smart automatic pet feeder with app control. Schedule meals, portion control, and feeding history.
From £49.99
Shop now
We may earn a small commission if you purchase through these links, at no extra cost to you.
Also in antibiotic
Related Medications
Actionis 50 mg/ml, Suspension for Injection for Pigs and Cattle
POM-VCeftiofur
injection
Rx
Cattle
Pigs
Actionis 50 mg/ml, Suspension for Injection for Pigs and Cattle
POM-VCeftiofur
injection
Rx
Cattle
Pigs
Adaxio Shampoo for Dogs
POM-VChlorhexidine Gluconate + Miconazole Nitrate
shampoo
Rx
Dogs
Adaxio Shampoo for Dogs
POM-VChlorhexidine Gluconate + Miconazole Nitrate
shampoo
Rx
Dogs
Advocin 180, 180 mg/ml, Solution for Injection for Cattle
POM-VDanofloxacin
injection
Rx
Cattle
Aivlosin 42.5 mg/g Oral Powder for Pigs
POM-VTylvalosin
powder
Rx
Pigs
Find cheaper vets near you
Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.